Further information
Summary
Now you have completed this module, you will be familiar with how products from the Mentholatum range can be recommended to customers affected by back pain.
You can also advise on the 5 simple S.T.E.P.S. to help manage and prevent back pain and refer customers to www.mindyourbackuk.com

Thank you for completing the module. Click next to test your learning.
The content of this material has been approved by the NPA. The NPA will have no liability to any person or entity with liability, loss or damage caused or alleged to have been caused directly or indirectly by information therein. The NPA is not responsible for the content of any non-NPA websites mentioned in this programme or for the accuracy of any information found there. The fact that a website, organisation or product is mentioned in the programme does not mean that the NPA either approves of it or endorses it.
References
1. https://www.nhs.uk/Conditions/Back-pain/
3. Mentholatum data on file
All references last accessed April 2019
Product Information
Deep Heat Heat Rub Product Information
Presentation: Cream containing methyl salicylate 12.80%w/w, menthol 5.91%w/w, eucalyptus oil 1.97%w/w and turpentine oil 1.47%w/w. Uses: For the symptomatic relief of muscular pains and stiffness, including: backache, sciatica, lumbago, fibrositis, rheumatic pain, chilblains, bruises and sprains including those caused by minor sports injuries. Dosage: For topical administration to adults and children over 5 years. Apply a thin layer to the affected part with gentle massage 2 to 3 times daily. Can be used before or after exercise. Contraindications: Hypersensitivity to any of the ingredients. Hypersensitivity to aspirin, ibuprofen or other non-steroidal anti-inflammatory drugs (including when taken by mouth) especially where associated with a history of asthma. Precautions: Caution is required in patients with asthma as salicylates may provoke bronchospasm. Salicylates can increase the effect of coumarin anticoagulants and anti-platelet medication, including aspirin. Patients should consult doctor before use if pregnant, breast-feeding, asthmatic or on any prescribed medicines. For external use and only on unbroken skin. Avoid contact with the eyes and sensitive areas of skin. Always try on a small area first. Some people may experience discomfort particularly those with sensitive skin or if used in hot weather or after a bath. Not for use with occlusive dressings. Wash hands immediately after use. Discontinue use if excessive irritation or other unwanted effects occur. If symptoms persist consult doctor. Pregnancy and lactation: Avoid use unless necessary. Side effects: It is possible that skin burns, blisters and temporary skin reactions such as redness, burning sensation and rashes may occur. Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.gov.uk . Legal category: GSL. RRP (ex-VAT): 35g £2.16, 67g £3.24, 100g £4.33. Marketing Authorisation Holder: The Mentholatum Company Limited, 1 Redwood Avenue, Peel Park Campus, East Kilbride, G74 5PE. MA number: PL 00189/5002R.
Date of preparation: January 2016.
Deep Relief Anti-Inflammatory Gel/Deep Relief Joint Pain Gel
Presentation: Gel containing ibuprofen 5.0%w/w, levomenthol 3.0%w/w. Uses: Relief of rheumatic pain, muscular aches, pains and swellings such as strains, sprains and sports injuries. [Also for the relief of the pain associataed with non-serious arthritic conditions - Deep Relief Joint Pain Gel 100g Pharmacy only]. Contraindications: Those patients known to be hypersensitive to ibuprofen, levomenthol, or any of the ingredients or sensitive to aspirin, or other NSAIDs including when taken by mouth, or asthmatic patients in whom aspirin or non-steroidal anti-inflammatories are known to precipitate asthmatic attacks, rhinitis or urticaria. Use on broken skin or denuded skin. Simultaneous use on the same site with any other topical medicine. Use in the presence of local infection. Use in the last trimester of pregnancy. Precautions: For external use only. Always try on a small area first. The gel should not be used on or near mucous membranes, nor near the eyes. Avoid contact with inflamed or broken skin. Discontinue use if rash or irritation develops. Not for use with occlusive dressings. As it is known that oral Ibuprofen may worsen an existing renal impairment, or aggravate an active peptic ulcer, patients with a history of renal problems or with an active peptic ulcer should seek medical advice before using topical Ibuprofen products. Wash hands after use unless they are being treated. If anyone swallows the gel he or she should contact his or her doctor or nearest casualty department. By extrapolation from other routes of administration: although this is less likely with NSAIDs intended for topical use compared to oral drugs, the use of these products, as with any drug known to inhibit cyclo-oxygenase/prostaglandin synthesis, may impair fertility. In women who have difficulty conceiving or who are undergoing investigation of infertility, withdrawal of these products should be considered. Consult doctor if patient experiences any unwanted effects, if there is no improvement, or the condition is aggravated. Concurrent use of aspirin or other NSAIDS may result in an increased incidence of adverse reactions. Pregnancy and lactation: Topical ibuprofen is not recommended during the first six months of pregnancy and is contraindicated in the last trimester of pregnancy. Lactation - not recommended. Side effects: Skin disorders are most frequently reported: Application site reactions such as, rashes, pruritus and urticaria, drying, reddening, burning sensation, contact dermatitis. Although extremely uncommon when administered topically side effects such as abdominal pain, dyspepsia and renal impairment are possible. Hypersensitivity reactions have been reported following treatment with ibuprofen. These may consist of (a) non-specific allergic reactions and anaphylaxis (b) respiratory tract reactivity comprising of asthma, aggravated asthma, dyspnoea and bronchospasm which may be precipitated in patients suffering from or with a previous history of bronchial asthma or allergic disease (c) assorted skin disorders, including rashes of various types, pruritus, urticaria, purpura, angioedema and, less commonly, bullous dermatoses (including epidermal necrolysis and erythema multiforme). Adverse events should be reported. Reporting forms and information can be found at www yellowcard.gov.uk. Legal category: Deep Relief Anti-Inflammatory Gel in 15, 30, 50 and 100g GSL; and Deep Relief Joint Pain Gel in 100g P. RRP (ex-VAT): 30g GSL £3.99, 50g GSL £4.99, 100g GSL £9.17, 100g P £9.17. Marketing Authorisation Holder: The Mentholatum Company Limited, 1 Redwood Avenue, Peel Park Campus, East Kilbride, G74 5PE. MA number: PL 00189/0027 Deep Relief Anti-Inflammatory Gel / PL 00189/0036 Deep Relief Joint Pain Gel.
Date of preparation: October 2018.